DHR vs MRVL: Which Is the Better Buy?
Side-by-side comparison of Danaher Corporation and Marvell Technology, Inc. — fair value, conviction, valuation metrics, and QuantHub research signals.
Updated 2026-06-20.
Danaher Corporation · Healthcare
$177.17
+8.9% upside to fair value
Grade B
High Quality
VS
Marvell Technology, Inc. · Technology
$310.58
-18.5% upside to fair value
Grade D
QuantHub Verdict
DHR has more upside to fair value
(+8.9%).
DHR trades at a lower forward P/E
(34.1x).
These are model outputs — not personalized investment advice.
See all research →
Valuation & Fundamentals
| Metric |
DHR |
MRVL |
| Current Price |
$177.17 |
$310.58 |
| Fair Value Estimate |
$192.90 |
$253.23 |
| Upside to Fair Value |
+8.9%
|
-18.5%
|
| Market Cap |
$125.4B |
$271.7B |
| Forward P/E |
34.1x
|
105.7x
|
| EV / EBITDA |
20.8x
|
59.1x
|
| Price / Sales |
5.1x
|
31.2x
|
| Price / FCF |
23.7x
|
163.2x
|
| Revenue Growth YoY |
+3.7%
|
+27.6%
|
| Gross Margin |
60.7%
|
50.6%
|
| Operating Margin |
21.0%
|
16.2%
|
| Return on Equity |
7.1%
|
16.8%
|
| Dividend Yield |
0% |
0% |
| FCF Yield |
4.22%
|
0.61%
|
| Analyst Consensus |
Strong Buy
|
Strong Buy
|
Investment Thesis
Danaher Corporation operates in the healthcare sector, specializing in medical diagnostics and research tools through three balanced platforms: Biotechnology, Life Sciences, and Diagnostics. The company benefits from a durable competitive moat supported by the Danaher Business System, disciplined capital allocation, and a platform-centric organizational structure. Despite modest revenue growth of…
Marvell Technology, Inc. designs and supplies semiconductor solutions primarily focused on data infrastructure markets including cloud, AI, carrier 5G, and custom silicon. The company benefits from a narrow but widening moat driven by strong IP and hyperscaler relationships, led by an experienced CEO with a track record of transformational M&A. Despite strong revenue growth of 42% year-over-year …
Accumulation Zones
| Metric |
DHR |
MRVL |
| Zone Low |
$144.68 |
$189.92 |
| Zone High |
$163.97 |
$215.25 |
| In Buy Zone? |
No
|
No
|